Onkos Surgical® Launches Precision Oncology Platform at 2017 Annual Musculoskeletal Tumor Society Meeting in Denver, Colorado

News provided by

Sep 27, 2017, 07:07 ET

PARSIPPANY, N.J., Sept. 27, 2017 /PRNewswire/ -- Onkos Surgical, Inc., a specialty medtech company dedicated to advancing innovation for the surgical oncology market announced today that it will launch a new service platform focused on preoperative surgical planning called Precision Oncology. The company will showcase the new platform at the upcoming Musculoskeletal Tumor Society (MSTS) held in Denver, Colorado.

"Onkos Surgical was founded to deliver meaningful innovation in the surgical oncology space. We recognize that musculoskeletal oncology is a challenging field as every patient is different, and these differences require a level of precision in surgical planning that delivers the type of personalization that every patient deserves," said Patrick Treacy, CEO and Co-founder. "In a short period of time, we have made significant investments to advance Onkos' surgical planning capabilities to enhance the surgeon experience in managing these complex cases."

"The heart of the Onkos Precision Oncology platform is uDesign™ Patient Solutions, a concierge level service that allows surgeons to create a surgical plan tailored to the specific needs of their patient. uDesign allows our Patient Solution Engineers to partner with surgeons to bring their detailed surgical plans to life," said Sean Curry, SVP of Commercial Operations. "The result is a level of pre-and intra-operative precision that reduces the number of surgical trays and other instrumentation required in the OR. We are creating a customer experience that simplifies and enhances the surgical planning algorithm."

Mr. Treacy added, "Our recent series B funding gives Onkos the opportunity to accelerate the execution of our innovation strategy. Based on the unique clinical challenges musculoskeletal surgeons and their patients face routinely, our company is developing technologies to address infection, aseptic loosening and soft tissue management. We will continue to expand our Precision Oncology offering to leverage our differentiated surgical planning platform, innovative 3D printed surgical solutions, and capitalize on our recent investments in a proprietary surface treatment technology. The combination of these assets enables Onkos to deliver a best in class product and service portfolio to address the unmet clinical challenges of our customers."

Steven Gitelis, MD, Onkos Surgical Medical Director and Endowed Professor, Department of Orthopedic Surgery and Director, Section of Orthopedic Oncology at Rush University Medical Center said, "Onkos Surgical is committed to solving the complex problems that my colleagues and I face daily. The Precision Oncology approach will provide surgeons with a new and differentiated way of planning their cases."

About Onkos Surgical
Based in Parsippany, NJ., Onkos Surgical is a privately held surgical oncology company founded in 2015. Onkos Surgical believes surgical oncology deserves attention, focus and innovation. Through dedication and strategic partnerships, Onkos Surgical will advance surgical oncology solutions and advocate for and support the surgeons and caregivers that dedicate their lives to the surgical treatment of cancer.

For more information, visit www.onkossurgical.com

Media contacts:
Sean Curry
Senior Vice President, Commercial Operations
[email protected]
(973) 264-5411

SOURCE Onkos Surgical